In August 2005, the United Kingdom's Human Fertilisation & Embryology Authority launched a public consultation, seeking views on the use of preimplantation genetic diagnosis for the detection of cancer genes. The issue was considered by the Authority to be a possible source of particular controversy because it involved extending the range of conditions for which PGD can be licensed in a potentially important way: As well as testing for genes that would definitely cause disease traits, such as cystic fibrosis and muscular dystrophy, this would involve genes that would only possibly manifest themselves phenotypically. In other words, there is a very real chance that such an application of PGD would result in the destruction of perfectly healthy embryos.
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI http://dx.doi.org/10.1017/S096318010707003X
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 70,163
Through your library

References found in this work BETA

No references found.

Add more references

Citations of this work BETA

Redefining Disability: Maleficent, Unjust and Inconsistent.B. Cox-White & S. F. Boxall - 2008 - Journal of Medicine and Philosophy 33 (6):558-576.
Response.Madelyn M. Peterson - 2008 - Journal of Bioethical Inquiry 5 (2-3):223-224.

Add more citations

Similar books and articles

Sex Selection and Preimplantation Genetic Diagnosis.Edgar Dahl - 2015 - In Helga Kuhse & Udo Schüklenk (eds.), Bioethics: An Anthology. Blackwell. pp. 141-143.
Preimplantation Genetic Diagnosis: Does Age of Onset Matter (Anymore)? [REVIEW]Timothy Krahn - 2009 - Medicine, Health Care and Philosophy 12 (2):187-202.


Added to PP index

Total views
53 ( #214,112 of 2,506,525 )

Recent downloads (6 months)
1 ( #416,791 of 2,506,525 )

How can I increase my downloads?


My notes